Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9743 USD | -1.58% | +13.29% | -12.23% |
Jul. 05 | Cytosorbents Corporation and Cytosorbents Medical, Inc. Enter Loan and Security Agreement | CI |
Jun. 28 | Cytosorbents Corporation announced that it expects to receive $20 million in funding | CI |
Financials (USD)
Sales 2024 * | 39.52M | Sales 2025 * | 46.83M | Capitalization | 52.91M |
---|---|---|---|---|---|
Net income 2024 * | -20M | Net income 2025 * | -9M | EV / Sales 2024 * | 1.34 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.13 x |
P/E ratio 2024 * |
-2.66
x | P/E ratio 2025 * |
-5.41
x | Employees | 186 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.8% |
Latest transcript on Cytosorbents Corporation
1 day | -1.58% | ||
1 week | +13.29% | ||
Current month | +38.59% | ||
1 month | +8.38% | ||
3 months | +7.68% | ||
6 months | -1.59% | ||
Current year | -12.23% |
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Vincent Capponi
PSD | President | 66 | 02-04-24 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 15-07-13 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Edward Jones
BRD | Director/Board Member | 75 | 07-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-11 | 0.9743 | -1.58% | 129,746 |
24-07-10 | 0.9899 | -1.99% | 66,223 |
24-07-09 | 1.01 | 0.00% | 458,470 |
24-07-08 | 1.01 | +11.12% | 234,610 |
24-07-05 | 0.9089 | +5.69% | 177,069 |
Delayed Quote Nasdaq, July 11, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.23% | 52.91M | |
+2.24% | 207B | |
+6.45% | 182B | |
+31.46% | 157B | |
+33.00% | 113B | |
+4.37% | 66.91B | |
+21.77% | 55.95B | |
-2.92% | 47.01B | |
-5.91% | 38.17B | |
+3.39% | 36.49B |
- Stock Market
- Equities
- CTSO Stock